vinpocetine has been researched along with Age-Related Macular Degeneration in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bönöczk, P; Cserjés, Z; Kiss, G; Szikszay, E; Végh, S | 1 |
Bandych-Biniszkiewiczowa, D; Pojda, SM | 1 |
Gerkowicz, K; Jankowska, I; Jedrzejewski, D; Szponar, B; Toczołowski, J | 1 |
1 trial(s) available for vinpocetine and Age-Related Macular Degeneration
Article | Year |
---|---|
[Clinical trials of using Cavinton in the form of intravenous infusion in the treatment of macular degeneration].
Topics: Aged; Clinical Trials as Topic; Female; Humans; Infusions, Intravenous; Macular Degeneration; Male; Middle Aged; Vinca Alkaloids | 1987 |
2 other study(ies) available for vinpocetine and Age-Related Macular Degeneration
Article | Year |
---|---|
[Retrospective analysis of the effect of vinpocetine infusion in ophthalmologic disorders].
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Diabetic Retinopathy; Eye Diseases; Female; Humans; Infusions, Intravenous; Macular Degeneration; Male; Middle Aged; Myopia; Ocular Hypertension; Optic Neuropathy, Ischemic; Retinitis Pigmentosa; Retrospective Studies; Time Factors; Treatment Outcome; Vinca Alkaloids; Vision Disorders; Vision, Ocular; Visual Fields | 2006 |
[Personal experiences with conservative treatment of central retinal degeneration].
Topics: Administration, Oral; Adult; Aged; Cinnarizine; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Macular Degeneration; Male; Middle Aged; Procaine; Vinca Alkaloids; Visual Acuity; Vitamins; Xanthinol Niacinate | 1992 |